Accudava, Inc
AccuDava, Inc., based in La Jolla, CA, is at the forefront of innovative cancer research, focusing on identifying patients who are resistant to standard platinum chemotherapy drugs. Their groundbreaking methods aim to reduce mortality rates by enabling personalized treatment strategies, particularly for ovarian and lung cancer patients.
The company has been recognized for its contributions with multiple awards, including Phase I Small Business Innovative Research Grants from the National Cancer Institute and the NIH-Innovative Corps grant. AccuDava is also developing a novel glycan-based technology to enhance drug entry into cancer cells, promising a paradigm shift in cancer treatment and significant improvements in patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

